When using nCPAP, the patient must be able to breathe spontaneously, since no breaths are administered. The continuous positive pressure ensures stabilization of the airways and lungs.
nCPAP is the most commonly used mode of non-invasive respiratory support in premature infants and newborns and is the basis of some further variants, such as NIPPV, SNIPPV and nHFV.All features
Apnea is detected by MediTRIG. As a result, breaths are automatically triggered to stimulate breathing. Frequency, pressure level and breath duration can be individually adjusted.
In addition to the PEEP, breaths with fixed settings (pressure level, duration, frequency) are administered. These breaths have a higher pressure level and are not emitted in a synchronized manner.All features
nHFT – nasal High Flow Therapy
nHFT describes the supply of heated and humidified breathing gas via a nasal cannula. The gas flow administered is thus higher than the patient’s inspiratory respiratory flow. In neonatology, a flow of more than 1 LPM is considered to be high-flow therapy, while for adults, correspondingly higher values should be applied.All features
The MediTRIG respiratory trigger was specially developed by medin for use in premature infants and newborns. Through the combination of the pressure measurement in the Medijet® generator and the signal processing in the medin nCPAP devices, MediTRIG works without additional sensors.
MediTRIG detects central as well as obstructive apnea.All features
Depending on your country, some features may be available as options, may have different specifications than described on this website, or may not be available. Contact your medin representative for details.